#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary neuropathic amyloidosis ROHHAD syndrome Gastrointestinal stromal tumour Short stature homeobox gene mutation Ewing's sarcoma Neuroblastoma CDKL5 deficiency disorder Sickle cell anaemia Congenital hypotransferrinaemia Spinal cord injury cervical Systemic scleroderma Cardiac amyloidosis Hereditary hypophosphataemic rickets Erdheim-Chester disease B precursor type acute leukaemia More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome – Life with Disease Arterial tortuosity syndrome – Basic Information Cytokine release syndrome – Diagnostics Wiskott-Aldrich syndrome – Life with Disease Marginal zone lymphoma refractory – Treatment Cerebral arteriovenous malformation haemorrhagic – Treatment Arterial tortuosity syndrome – Trials in Disease Crigler-Najjar syndrome – Diagnostics Primary hyperoxaluria – Trials in Disease Metachromatic leukodystrophy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Fluoride (18F) Ocrelizumab Pazopanib Alternaria Alternata (402) Valoctocogene Roxaparvovec Erdafitinib Tucatinib Etelcalcetide OLVEREMBATINIB Mva-209-Fsp-B4 Belumosudil Mesilate Benzalkonium Chloride Chlorpromazine Formoterol Fumarate Dihydrate Urea Secukinumab DISODIUM PHOSPHATE Sotalol Magnesium Chloride Nmd670 More therapies…

    Learn about Your Condition

    Round cell liposarcoma Hip arthroplasty EGFR gene mutation Cold type haemolytic anaemia Lymphocytic leukaemia Osteoarthritis Neonatal anoxia Plasma cell myeloma refractory Carotid artery occlusion Diarrhoea Tuberculosis Coma Uveitis Cardiac failure chronic Colorectal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Short-term Interruption vs. Continuous Anticoagulation with Apixaban in Patients Undergoing Colorectal Polypectomy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acenocoumarol
    • Warfarin Sodium
    • Lactose Monohydrate
    Spain

  • Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium Croatia Czechia France Germany +8

  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Risankizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • Mdna11
    • Pembrolizumab
    Ireland Poland Portugal Spain

  • Study on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pouchitis
    Investigated Drugs:
    • Rifamycin Sodium
    • Vedolizumab
    • Amoxicillin Sodium
    Belgium Croatia Czechia Denmark Greece Italy +2

  • Study on Dapagliflozin for Patients with Decompensated Liver Cirrhosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cirrhosis alcoholic
    • Hepatic cirrhosis
    Investigated Drugs:
    • Dapagliflozin
    Italy
Previous Page
1 … 33 34 35 36 37 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!